The Tate galleries and the National Portrait Gallery in London say they will no longer accept money from the Sacklers, the family who made, marketed and profited OxyContin through its company, Purdue Pharma. Marco Werman speaks to Benjamin Soskis, an expert on philanthropy at the Urban Institute. Is this a watershed moment in the controversy over cultural institutions funded by the Sacklers?
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.